Home » Topics » Patents, BioWorld Science

Patents, BioWorld Science
RSS

Potential new antimigraine agents in development at Allelix

Feb. 12, 1998

Byk Gulden describes new imidazopyridine PDE IV inhibitors

Feb. 12, 1998

Icos reveals new cGMP-specific PDE inhibitors

Feb. 12, 1998

Adenosine agonists with antilipolytic activity described by Glaxo

Feb. 12, 1998

Novel compound MK6059 isolated by Meiji Seika/Mitsubishi Chemical

Feb. 11, 1998

Potent and safe new quinolones from Daiichi

Feb. 11, 1998

Novel mitomycin C derivative reported by Sagami

Feb. 11, 1998

New agents for IBS from Nippon Shinyaku

Feb. 11, 1998

Several related series of MMP inhibitors claimed by Bayer

Feb. 9, 1998

Schering-Plough discloses HCV NS3 protease inhibitors

Feb. 9, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 20, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 20, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...